期刊文献+

Smac/DIABLO与Livin在乳腺癌组织表达及其临床意义 被引量:2

Expressions of Smac/DIABLO and Livin in breast cancer and their clinical significance
在线阅读 下载PDF
导出
摘要 目的:探讨凋亡促进因子Smac/DIABLO和凋亡抑制因子Livin在人乳腺癌组织中的表达及相关性,分析其与乳腺癌转移复发的关系。方法:应用免疫组织化学SP法检测76例乳腺癌组织和相应的癌旁组织中Livin和Smac蛋白的表达情况。结果:76例乳腺癌组织中Livin蛋白表达的阳性率为67.8%(51/76),显著高于相应的癌旁组织的59.2%(36/76),P<0.05;乳腺癌组织中Smac表达为52.6%(40/76),显著低于癌旁组织的75.0%(57/76),P<0.05。两者的表达与组织学分级、肿瘤大小、腋窝淋巴结转移以及术后复发密切相关,P<0.05。Livin和Smac表达呈显著负相关,γ=-0.238,P<0.05。结论:Livin的高表达及Smac/DIABLO的低表达或失活可能在乳腺癌的发生、发展中起重要作用。 Objective:To investigate the expressions of Smac/DIABLO and Livin in breast carcer and their correlation with metastasis and recurrence.Methods: Immunohistochemisty was employed to determine the expressions of Livin and Smac in 76 breast carcinomas and paired adjacent breast tissues.Results: Smac/DIABLO was significantly lower in breast cancer(52.6%,40/76) compared with the paired adjacent breast tissues(75.0%,57/76)(P0.05)and Livin was overexpressed in breast cancers(67.8 %,51/76)compared with the paired adjacent breast tissues(59.2%,36/76)(P 0.05).The protein expressions of Smac/DIABLO and Livin were significantly correlated with the histological grade diameter of tumour,axillary lymph node metastasis and recurrence of tumor(P 0.05).There was a significantly negative relationship between Livin and Smac/DIABLO(γ=-0.238,P0.05).Conclusion: The inactivation of Smac/DIABLO and overexpression of Livin protein might enhance the tumour cell proliferation and malignance and play an important role in progress of human breast cancer.
出处 《现代肿瘤医学》 CAS 2011年第11期2236-2238,共3页 Journal of Modern Oncology
关键词 乳腺癌 SMAC/DIABLO LIVIN breast carcinoma Smac/DIABLO Livin
  • 相关文献

参考文献3

二级参考文献32

  • 1杨景,柳凤轩,阎晓初,贺光友,刘丽梅.Survivin在结直肠癌组织中表达的临床意义及其与细胞凋亡、血管生成的关系[J].癌症,2005,24(1):116-120. 被引量:21
  • 2宋玉成,万德森,潘志忠,周志伟,陈功,伍小军,李力人,卢震海,丁培荣.Survivin在Dukes’C期结直肠癌中的表达及其生物学意义[J].中国肿瘤临床,2005,32(17):979-983. 被引量:15
  • 3[1]Lin J H,Deng G,Huang Q,et al.KIAP,a novel member of the inhibitor of apoptosis protein family[J].Biochem Biophys Res Commun,2000,279 (3):820-831.
  • 4[2]Vucic D,Stennicke H R,Pisabarro M T,et al.ML-IAP,a novel inhibitor of that is preferentially expressed in human[J].Curr Biol,2000,10 (21):1359-1366.
  • 5[3]Kasof G M,Gomes B C.Livin,a novel inhibitor of apoptosis protein familly member[J].J Biol Chem,2001,276 (5):3238-3246.
  • 6[4]Du C,Fang M,Li Y,et al.Smac,a mitochondrial protein that promotes cytochrome c-dependent Caspase activation by eliminating IAP inhibition[J].Cell,2000,102(1):33-42.
  • 7[5]Verhagen A M,Ekert P G,Pakusch M,et al.Identification of DIABLO,a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins[J].Cell,2000,102 (1):43-53.
  • 8[6]Falleni M,Pelleqrini C,Marchetti A,et al.Survivin gene expression in early-stage non-small cell lung cancer[J].J Pathol,2003,200 (5):620-626.
  • 9[7]Ashhab Y,Alian A,Polliack A,et al.Two splicing variants of a new inhibitor of apoprosis gene with different biogical properties and tissue distribution pattern[J].FEBS Lett,2001,495 (1-2):56-60.
  • 10[9]Hariu H,Hirohashi Y,Torigoe T,et al.Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family,Livin/ML-IAP in lung cancer[J].Clin Cancer Res,2005,11 (3):1000-1009.

共引文献77

同被引文献12

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部